Response Genetics Statistics
Total Valuation
Response Genetics has a market cap or net worth of 39.
| Market Cap | 39 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Response Genetics has 38.80 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 38.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80
| Current Ratio | 1.80 |
| Quick Ratio | 1.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.83 |
| Interest Coverage | -13.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.88% |
| Return on Capital (ROIC) | -176.16% |
| Revenue Per Employee | 169,551 |
| Profits Per Employee | -145,034 |
| Employee Count | 98 |
| Asset Turnover | 1.32 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 3.90 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 29.13 |
| Average Volume (20 Days) | 1,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Response Genetics had revenue of 16.62 million and -14.21 million in losses. Loss per share was -0.37.
| Revenue | 16.62M |
| Gross Profit | 6.25M |
| Operating Income | -13.65M |
| Pretax Income | -14.21M |
| Net Income | -14.21M |
| EBITDA | -12.84M |
| EBIT | -13.65M |
| Loss Per Share | -0.37 |
Balance Sheet
The company has 1.73 million in cash and 10.94 million in debt, giving a net cash position of -9.21 million or -0.24 per share.
| Cash & Cash Equivalents | 1.73M |
| Total Debt | 10.94M |
| Net Cash | -9.21M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | -4.94M |
| Book Value Per Share | -0.13 |
| Working Capital | 3.88M |
Cash Flow
In the last 12 months, operating cash flow was -13.09 million and capital expenditures -22,278, giving a free cash flow of -13.11 million.
| Operating Cash Flow | -13.09M |
| Capital Expenditures | -22,278 |
| Free Cash Flow | -13.11M |
| FCF Per Share | -0.34 |
Margins
Gross margin is 37.60%, with operating and profit margins of -82.15% and -85.54%.
| Gross Margin | 37.60% |
| Operating Margin | -82.15% |
| Pretax Margin | -85.54% |
| Profit Margin | -85.54% |
| EBITDA Margin | -77.26% |
| EBIT Margin | -82.15% |
| FCF Margin | n/a |
Dividends & Yields
Response Genetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.91% |
| Shareholder Yield | -10.91% |
| Earnings Yield | -36,444,366.67% |
| FCF Yield | -33,609,417.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Response Genetics has an Altman Z-Score of -11.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.94 |
| Piotroski F-Score | n/a |